Read the full deal writeup
Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.
Get Free AccessFull Editorial Writeup
Our Client has developed an AI medical assistant suite of software products that provides solutions customizable for any clinic, medical practice or hospital. Our Client’s suite of products is in use in 12 medical industry facilities, with a user interface that includes both a patient facing and a care team facing interface. The revolutionary "AI agents" are designed to automate clinical and operational workflows that resolve the majority of issues with healthcare.The system amplifies patient participation while streamlining provider tasks in both the administrative and medical spheres and includes a full AI medical scribe. The flexibility to integrate with almost any EMR (Electronic Medical Record) makes it widely applicable throughout the medical industry. Our Client has strategic partnerships with the prestigious Mayo Clinic and the third largest EMR "Athena Health" which provides access to 160,000+ doctors. The company has raised $37.9M in total capital including $22.5M from funding rounds, with impressive revenue projections showing $107.4M Annual Recurring Revenue by 2027. This company improves all clinic business metrics, most notably increasing profitability from an average of 3% to over 30% net profit. With 28 patents in 14 patent families covering AI technologies and medical automation worldwide, this represents a significant opportunity in a $31 billion addressable healthcare IT market.NDA required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Why we like it
- Earnings Quality is strong with $825K cash flow on $1.6M revenue representing a healthy 51.6% margin, typical of mature SaaS businesses with proven product-market fit. The revenue model appears to be recurring given the SaaS nature and integration with critical healthcare infrastructure, providing predictable cash generation.
- Durability stems from deep healthcare system integration and switching costs inherent in EMR-connected AI workflows that become embedded in daily clinical operations. The 28 patents across 14 families create meaningful IP moats, while partnerships with Mayo Clinic and Athena Health provide distribution advantages and competitive barriers.
- Market Tailwinds include the massive $31 billion healthcare IT addressable market and accelerating healthcare automation adoption post-pandemic. Healthcare providers face persistent staffing shortages and margin pressure, making AI solutions that demonstrably improve profitability from 3% to 30% increasingly essential rather than optional.
- Operator Advantage lies in the proven ability to dramatically improve client economics, with current deployment across 12 facilities providing case studies and references for expansion. The Athena Health partnership alone provides access to 160,000+ doctors, creating a clear path to scale the existing proven solution rather than building from scratch.
How to improve it
- Accelerate customer acquisition through the Athena Health partnership by developing a structured outreach program targeting their 160,000+ doctor network with case studies from existing deployments. Focus on the 30% profitability improvement metric as the primary value proposition to drive faster sales cycles and higher conversion rates.
- Expand recurring revenue streams by developing tiered pricing models based on facility size and feature usage, potentially adding premium AI capabilities or advanced analytics modules. The current 51.6% margins suggest room for premium pricing on enhanced features that further automate workflows.
- Systematize implementation and onboarding processes to reduce customer acquisition costs and time-to-value for new healthcare clients. Standardize integration protocols for the most common EMR systems beyond Athena to streamline deployment and reduce custom development work per client.
- Develop strategic partnerships with additional EMR providers and healthcare systems to diversify distribution channels beyond the current Mayo Clinic and Athena relationships. Target mid-market EMR providers to capture smaller practices that may be underserved by enterprise solutions.
- Build a customer success program focused on maximizing utilization and demonstrating ROI to drive expansion revenue within existing accounts. Track and report on key metrics like workflow automation rates and profitability improvements to support upselling and contract renewals.
- Explore acquisition opportunities for complementary healthcare AI tools or smaller competitors to consolidate market share and expand the product suite. The strong cash generation and established partnerships provide a platform for strategic roll-up opportunities.
- Develop industry-specific versions of the AI assistant for specialized medical practices like cardiology, orthopedics, or mental health to command premium pricing and reduce competitive threats from generalist solutions.
- Create a robust referral program leveraging satisfied customers in the 12 current deployments to generate qualified leads and reduce customer acquisition costs through word-of-mouth marketing within healthcare networks.
Diligence notes
- Verify the claimed profitability improvements from 3% to 30% by reviewing actual client financial data and testimonials, as this extraordinary ROI claim is central to the value proposition. Request case studies with specific metrics and timelines to validate the business impact assertions.
- Analyze customer concentration risk across the 12 current facilities and understand contract terms, renewal rates, and churn patterns. Determine if any single customer represents a disproportionate share of revenue and assess the stability of existing recurring revenue streams.
- Examine the patent portfolio strength and competitive landscape to understand true defensibility, particularly focusing on the enforceability of the 28 patents and potential infringement risks from larger healthcare IT players. Review any ongoing or potential IP litigation.
- Scrutinize the revenue projections showing growth to $107.4M ARR by 2027 and understand the assumptions behind these forecasts, including customer acquisition rates, pricing models, and market penetration expectations. Validate the scalability of current sales and implementation processes to support this growth trajectory.